Literature DB >> 1306097

Identification of women at increased risk for breast cancer in a population-based screening program.

M L Bondy1, V G Vogel, S Halabi, E D Lustbader.   

Abstract

A multivariate model to assess breast cancer risk was developed by Gail et al. (M. H. Gail, L. A. Brinton, D. B. Byar, D. K. Corle, S. B. Green, C. Schairer, and J. J. Mulvihill, J. Natl. Cancer Inst., 81: 1879-1886, 1989) based on data analysis of the Breast Cancer Detection and Demonstration Project. We evaluated the model's usefulness for assigning women to risk groups for counseling and follow-up by applying it to the 1987 Texas Breast Screening Project data. We identified 3165 women with one or more first-degree relatives affected with breast cancer. The mean risk score for the group was 3.3 (range, 2.7-11.8), indicating a greater than 3-fold elevated risk. The mean risk score for the remaining 27,439 women without affected first-degree relatives was 1.5 (range, 1.24-3.2). Risk perception was found to be a motivator for participation. Women with a risk score greater than 5 perceived themselves to be at high risk for breast cancer. The perception of risk was related to the type of affected first-degree relatives: 80.0% of the women with three affected first-degree relatives and 71.5% of women whose mother and sister were both affected with breast cancer perceived themselves to be at high risk. The Gail model is potentially useful in the clinical setting because women at high risk for breast cancer can be entered into etiological studies, enrolled in primary prevention trials, or referred to programs seeking to improve compliance with screening mammography. The Gail model needs validation, but it is useful for estimating the risk of breast cancer in large populations.

Entities:  

Mesh:

Year:  1992        PMID: 1306097

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

Review 1.  Adherence and psychological adjustment among women at high risk for breast cancer.

Authors:  C Lerman; M Schwartz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

2.  Prostate cancer knowledge in Irish men.

Authors:  Rowan G Casey; David J Rea; Ted McDermott; Ronald Grainger; Michael Butler; J A Thornhill
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

3.  Knowledge, attitudes, and practices surrounding breast cancer and screening in female teachers of buraidah, saudi arabia.

Authors:  Khadiga F Dandash; Abdurrahman Al-Mohaimeed
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

Review 4.  Clinical management of women at increased risk for breast cancer.

Authors:  V G Vogel; A Yeomans; E Higginbotham
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

5.  Factors associated with perceived risk of breast cancer among women attending a screening program.

Authors:  S W Vernon; V G Vogel; S Halabi; M L Bondy
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

6.  Mammography and physician breast exams after the diagnosis of breast cancer in a twin or non-twin sister.

Authors:  J L Richardson; K Danley; G T Mondrus; D Deapen; T Mack
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

7.  Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).

Authors:  D de Silva; F Gilbert; G Needham; H Deans; P Turnpenny; N Haites
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

8.  Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Authors:  C J Fabian; C Zalles; S Kamel; B F Kimler; R McKittrick; A S Tranin; S Zeiger; W P Moore; R S Hassanein; C Simon
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Factors influencing cancer risk perception in high risk populations: a systematic review.

Authors:  Jon C Tilburt; Katherine M James; Pamela S Sinicrope; David T Eton; Brian A Costello; Jantey Carey; Melanie A Lane; Shawna L Ehlers; Patricia J Erwin; Katherine E Nowakowski; Mohammad H Murad
Journal:  Hered Cancer Clin Pract       Date:  2011-05-19       Impact factor: 2.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.